168 related articles for article (PubMed ID: 15864139)
1. Pharmacogenetic testing for drug metabolizing enzymes: is it happening in practice?
Gardiner SJ; Begg EJ
Pharmacogenet Genomics; 2005 May; 15(5):365-9. PubMed ID: 15864139
[TBL] [Abstract][Full Text] [Related]
2. The clinical role of genetic polymorphisms in drug-metabolizing enzymes.
Tomalik-Scharte D; Lazar A; Fuhr U; Kirchheiner J
Pharmacogenomics J; 2008 Feb; 8(1):4-15. PubMed ID: 17549068
[TBL] [Abstract][Full Text] [Related]
3. [State of the art of pharmacogenetic diagnostics in drug therapy].
Kirchheiner J; Seeringer A; Brockmöller J
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Oct; 49(10):995-1003. PubMed ID: 17013776
[TBL] [Abstract][Full Text] [Related]
4. Clinical pharmacogenetics and potential application in personalized medicine.
Zhou SF; Di YM; Chan E; Du YM; Chow VD; Xue CC; Lai X; Wang JC; Li CG; Tian M; Duan W
Curr Drug Metab; 2008 Oct; 9(8):738-84. PubMed ID: 18855611
[TBL] [Abstract][Full Text] [Related]
5. Pharmacogenetics, drug-metabolizing enzymes, and clinical practice.
Gardiner SJ; Begg EJ
Pharmacol Rev; 2006 Sep; 58(3):521-90. PubMed ID: 16968950
[TBL] [Abstract][Full Text] [Related]
6. Increasing relevance of pharmacogenetics of drug metabolism in clinical practice.
Pillans PI
Intern Med J; 2001 Nov; 31(8):476-8. PubMed ID: 11720061
[TBL] [Abstract][Full Text] [Related]
7. [Diagnosis of hepatic enzyme activities of drug metabolizing enzymes-phenotyping and genotyping].
Ozawa S
Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 1999; (117):63-76. PubMed ID: 10859937
[TBL] [Abstract][Full Text] [Related]
8. Role of pharmacogenetics of drug-metabolizing enzymes in treating osteosarcoma.
Hattinger CM; Serra M
Expert Opin Drug Metab Toxicol; 2015; 11(9):1449-63. PubMed ID: 26095223
[TBL] [Abstract][Full Text] [Related]
9. Cytochrome p450 phenotyping/genotyping in patients receiving antipsychotics: useful aid to prescribing?
Dahl ML
Clin Pharmacokinet; 2002; 41(7):453-70. PubMed ID: 12083975
[TBL] [Abstract][Full Text] [Related]
10. How to manage individualized drug therapy: application of pharmacogenetic knowledge of drug metabolism and transport.
Meisel C; Roots I; Cascorbi I; Brinkmann U; Brockmöller J
Clin Chem Lab Med; 2000 Sep; 38(9):869-76. PubMed ID: 11097342
[TBL] [Abstract][Full Text] [Related]
11. Clinical implications of pharmacogenetics of cytochrome P450 drug metabolizing enzymes.
Kirchheiner J; Seeringer A
Biochim Biophys Acta; 2007 Mar; 1770(3):489-94. PubMed ID: 17113714
[TBL] [Abstract][Full Text] [Related]
12. Effects of Khat (Catha edulis) use on catalytic activities of major drug-metabolizing cytochrome P450 enzymes and implication of pharmacogenetic variations.
Bedada W; de Andrés F; Engidawork E; Hussein J; LLerena A; Aklillu E
Sci Rep; 2018 Aug; 8(1):12726. PubMed ID: 30143732
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenetic genotype and phenotype frequencies in a large Danish population-based case-cohort sample.
Lunenburg CATC; Thirstrup JP; Bybjerg-Grauholm J; Bækvad-Hansen M; Hougaard DM; Nordentoft M; Werge T; Børglum AD; Mors O; Mortensen PB; Gasse C
Transl Psychiatry; 2021 May; 11(1):294. PubMed ID: 34006849
[TBL] [Abstract][Full Text] [Related]
14. Pharmacogenetic phenotyping and genotyping. Present status and future potential.
Gonzalez FJ; Idle JR
Clin Pharmacokinet; 1994 Jan; 26(1):59-70. PubMed ID: 8137598
[TBL] [Abstract][Full Text] [Related]
15. Toward individualized treatment: prediction of anticancer drug disposition and toxicity with pharmacogenetics.
Deeken JF; Figg WD; Bates SE; Sparreboom A
Anticancer Drugs; 2007 Feb; 18(2):111-26. PubMed ID: 17159598
[TBL] [Abstract][Full Text] [Related]
16. Genotype and phenotype concordance for pharmacogenetic tests through proficiency survey testing.
Wu AH
Arch Pathol Lab Med; 2013 Sep; 137(9):1232-6. PubMed ID: 23991737
[TBL] [Abstract][Full Text] [Related]
17. Present status and perspective of pharmacogenetics in Mexico.
Cuautle-Rodríguez P; Llerena A; Molina-Guarneros J
Drug Metabol Drug Interact; 2014; 29(1):37-45. PubMed ID: 24129103
[TBL] [Abstract][Full Text] [Related]
18. Lessons from Cuba for Global Precision Medicine: CYP2D6 Genotype Is Not a Robust Predictor of CYP2D6 Ultrarapid Metabolism.
Dorado P; González I; Naranjo ME; de Andrés F; Peñas-Lledó EM; Calzadilla LR; LLerena A
OMICS; 2017 Jan; 21(1):17-26. PubMed ID: 28271978
[TBL] [Abstract][Full Text] [Related]
19. Pharmacogenetic methods as a complement to therapeutic monitoring of antidepressants and neuroleptics.
Dahl ML; Sjöqvist F
Ther Drug Monit; 2000 Feb; 22(1):114-7. PubMed ID: 10688272
[TBL] [Abstract][Full Text] [Related]
20. Influence of pharmacogenetics on drug disposition and response.
Eichelbaum M; Evert B
Clin Exp Pharmacol Physiol; 1996; 23(10-11):983-5. PubMed ID: 8911746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
